We assessed whether Medicaid expansion has led to more timely treatment of metastatic renal cell carcinoma (mRCC). We compared the time to treatment before and after expansion between the states that had and had not expanded Medicaid for patients with mRCC within the National Cancer Database. Medicaid expansion was not associated with more timely treatment for patients with mRCC.
- Health Insurance
- Patient Protection and Affordable Care Act
- United States
ASJC Scopus subject areas